Susquehanna International Group
VTAE

Susquehanna International Group’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Susquehanna International Group’s Portfolio VTAE Stock Details VTAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-62,815
Closed -$1.31M – 10620
2016
Q3 		$1.31M Buy
+62,815
New +$723K ﹤0.01% 4289
2016
Q2 		– Sell
-11,660
Closed -$77K – 9901
2016
Q1 		$77K Buy
+11,660
New +$106K ﹤0.01% 8533
2015
Q1 		– Sell
-20,687
Closed -$344K – 10378
2014
Q4 		$344K Buy
+20,687
New +$302K ﹤0.01% 7898

Susquehanna International Group's VTAE Position: Q4 2016 in Review

Susquehanna International Group sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 62,815 shares — an estimated $1.31M sold.

Susquehanna International Group first reported a position in VTAE in Q4 2014 and held it in 3 quarters. The position peaked at $1.31M in Q3 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

  • Susquehanna International Group reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
  • Susquehanna International Group sold 62,815 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $1.31M.
  • Susquehanna International Group first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q4 2014 and held it in 3 quarters.
  • Susquehanna International Group's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $1.31M in Q3 2016.
  • 0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on Susquehanna International Group's 13F filing for Q4 2016, filed 14 Feb 2017.